Co-Diagnostics Net Income 2017-2023 | CODX
Co-Diagnostics net income from 2017 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Co-Diagnostics Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-35 |
| 2022 | $-14 |
| 2021 | $37 |
| 2020 | $42 |
| 2019 | $-6 |
| 2018 | $-6 |
| 2017 | $-7 |
| 2016 | $-2 |
| Co-Diagnostics Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-15 |
| 2023-09-30 | $-6 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $-22 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $12 |
| 2021-12-31 | $7 |
| 2021-09-30 | $11 |
| 2021-06-30 | $10 |
| 2021-03-31 | $8 |
| 2020-12-31 | $13 |
| 2020-09-30 | $16 |
| 2020-06-30 | $15 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-1 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-1 |
| 2016-12-31 | |
| 2016-09-30 | $-0 |
| 2016-06-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.035B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.258B | 15.59 |
| Cencora (COR) | United States | $44.266B | 17.26 |
| ICON (ICLR) | Ireland | $26.033B | 24.58 |
| DiDi Global (DIDIY) | China | $23.379B | 0.00 |
| Avantor (AVTR) | United States | $17.056B | 25.11 |
| CochLear (CHEOY) | Australia | $14.191B | 0.00 |
| Viatris (VTRS) | United States | $13.264B | 3.96 |
| Revvity (RVTY) | United States | $13.145B | 23.06 |
| Natera (NTRA) | United States | $12.958B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.348B | 40.62 |
| Charles River Laboratories (CRL) | United States | $11.993B | 22.96 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.923B | 0.00 |
| Solventum (SOLV) | United States | $11.243B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $6.591B | 49.24 |
| Organon (OGN) | United States | $5.491B | 5.21 |
| Bausch + Lomb (BLCO) | Canada | $5.234B | 20.97 |
| Doximity (DOCS) | United States | $4.386B | 32.65 |
| PACS (PACS) | United States | $4.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.426B | 31.35 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Life Times (LTH) | United States | $2.939B | 30.79 |
| GoodRx Holdings (GDRX) | United States | $2.627B | 95.00 |
| Progyny (PGNY) | United States | $2.617B | 45.05 |
| AMN Healthcare Services Inc (AMN) | United States | $2.370B | 9.39 |
| Premier (PINC) | United States | $2.365B | 8.85 |
| Agilon Health (AGL) | United States | $2.262B | 0.00 |
| NovoCure (NVCR) | Jersey | $2.187B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.161B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.936B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.618B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.338B | 0.00 |
| Embecta (EMBC) | United States | $0.842B | 5.73 |
| CareDx (CDNA) | United States | $0.794B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.714B | 7.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.453B | 45.20 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| ModivCare (MODV) | United States | $0.384B | 7.18 |
| MultiPlan (MPLN) | United States | $0.364B | 0.00 |
| Beauty Health (SKIN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.344B | 18.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.281B | 0.00 |
| Sharecare (SHCR) | United States | $0.273B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.271B | 0.00 |
| Biodesix (BDSX) | United States | $0.171B | 0.00 |
| So-Young (SY) | China | $0.126B | 42.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.77 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |